Private limited company · founded 2013 · active for 13 yearsBroekstraat 28, 9255 Buggenhout, BelgiumKBO/BCE: BE 0539.740.563
Summary
JANPHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €321,854 and a net result of €46,550. Equity is growing by about 22% per year across the filed financial years. Its solvency ranks better than 30% of 6,577 sector peers (NACE 64, financial year 2025). The company has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals.
The company's story in a few sentences, from the company register, the Belgian Official Gazette and the filed annual accounts. Each number opens the document the sentence rests on.
On 30 September 2013, JANPHARMA was incorporated.1Total assets went from €1.1m in 2018 to €1.1m in 2025.2
A profit in every financial year since 2018 builds equity to €121,638.
11-07
NBB filingAnnual accounts filed
financial year 2018 · micro format
2018
25-07
NBB filingAnnual accounts filed
financial year 2017 · micro format
2017
30-08
NBB filingAnnual accounts filed
financial year 2016 · abbreviated format · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 12 annual accounts filed, the latest 10 are here; all 12 are under Financials.
0 of 2 deeds read
About the unread acts
We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.